Publisher: Icon Group International, Inc.
Category: Cancer Treatment

Cancer Treatment market research reports by Icon Group International, Inc.

(196 reports matching your criteria)
    • The 2025-2030 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care

      The 2025-2030 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care This study covers the world outlook for granulocyte colony stimulating factor (g-CSF) cancer supportive care across more than 190 countries. For each year reported, estimates are given for the latent ... Read More

    • The 2025-2030 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings

      The 2025-2030 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings This study covers the world outlook for fecal occult blood tests for in-vitro colorectal cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent dem ... Read More

    • The 2025-2030 World Outlook for Central Nervous System Lymphoma

      The 2025-2030 World Outlook for Central Nervous System Lymphoma This study covers the world outlook for central nervous system lymphoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Checkpoint Inhibitors

      The 2025-2030 World Outlook for Checkpoint Inhibitors This study covers the world outlook for checkpoint inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Photopheresis Products

      The 2025-2030 World Outlook for Photopheresis Products This study covers the world outlook for photopheresis products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Cervical Cancer Diagnostic Testing

      The 2025-2030 World Outlook for Cervical Cancer Diagnostic Testing This study covers the world outlook for cervical cancer diagnostic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More

    • The 2025-2030 World Outlook for Cervical Cancer Treatments

      The 2025-2030 World Outlook for Cervical Cancer Treatments This study covers the world outlook for cervical cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Stomach and Gastric Cancer Treatments

      The 2025-2030 World Outlook for Stomach and Gastric Cancer Treatments This study covers the world outlook for stomach and gastric cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More

    • The 2025-2030 World Outlook for Hodgkins Lymphoma Drugs

      The 2025-2030 World Outlook for Hodgkins Lymphoma Drugs This study covers the world outlook for Hodgkins lymphoma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Angiogenesis Inhibitors and Stimulators

      The 2025-2030 World Outlook for Angiogenesis Inhibitors and Stimulators This study covers the world outlook for angiogenesis inhibitors and stimulators across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2025-2030 World Outlook for Melanoma Diagnostics and Therapeutics

      The 2025-2030 World Outlook for Melanoma Diagnostics and Therapeutics This study covers the world outlook for melanoma diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More

    • The 2025-2030 World Outlook for Cancer Registry Software

      The 2025-2030 World Outlook for Cancer Registry Software This study covers the world outlook for cancer registry software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Cancer Screenings

      The 2025-2030 World Outlook for Cancer Screenings This study covers the world outlook for cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Cancer Specialty Hospitals

      The 2025-2030 World Outlook for Cancer Specialty Hospitals This study covers the world outlook for cancer specialty hospitals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Cancer Therapeutics

      The 2025-2030 World Outlook for Cancer Therapeutics This study covers the world outlook for cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Pancreatic Cancer Drugs

      The 2025-2030 World Outlook for Pancreatic Cancer Drugs This study covers the world outlook for pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing

      The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing This study covers the world outlook for pap smear tests for cervical cancer diagnostic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More

    • The 2025-2030 World Outlook for Cancer Stem Cells

      The 2025-2030 World Outlook for Cancer Stem Cells This study covers the world outlook for cancer stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Cancer Supportive Care

      The 2025-2030 World Outlook for Cancer Supportive Care This study covers the world outlook for cancer supportive care across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Cancer Testing-Screening

      The 2025-2030 World Outlook for Cancer Testing-Screening This study covers the world outlook for cancer testing-screening across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Cancer Diagnostics

      The 2025-2030 World Outlook for Cancer Diagnostics This study covers the world outlook for cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Urothelial Cancer Drugs

      The 2025-2030 World Outlook for Urothelial Cancer Drugs This study covers the world outlook for urothelial cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Ovarian Cancer Diagnostics

      The 2025-2030 World Outlook for Ovarian Cancer Diagnostics This study covers the world outlook for ovarian cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Ovarian Cancer Drugs

      The 2025-2030 World Outlook for Ovarian Cancer Drugs This study covers the world outlook for ovarian cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Breast Cancer Imaging Devices

      The 2025-2030 World Outlook for Breast Cancer Imaging Devices This study covers the world outlook for breast cancer imaging devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

1 2 3 4 5 6 7 8

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings